TG Therapeutics Inc (NASDAQ: TGTX) stock suffered a major decline of -15.4% on 1/10/24. The shares closed at $17.77. Moreover, exceptionally high trading volume at 403% of normal accompanied the decline. The stock has risen 4.3% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, TGTX is expected to be Value Creation neutral.
TG Therapeutics has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. TG Therapeutics has a poor Power Rating of 16 and a very low Appreciation Score of 0, triggering the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment